| Original language | English (US) |
|---|---|
| Pages (from-to) | 693-702 |
| Number of pages | 10 |
| Journal | Gastroenterology |
| Volume | 158 |
| Issue number | 3 |
| DOIs | |
| State | Published - Feb 2020 |
Bibliographical note
Funding Information:Funding This work was supported in part by the National Cancer Institute (NCI) of the National Institutes of Health (NIH) under Award Numbers R37 CA222866; 1UG3CA233314-01A1; and DK120515; and the Department of Veterans Affairs under Award Number I01 HX001574.
Funding Information:
The guideline panel included gastroenterologists (S.G., D.L., and H.E.), guideline methodologist trainees (P.D. and O.A.), and GRADE experts (S.S., Y.F.Y., and R.A.M.). The guideline panel worked closely with TR team members who reviewed the evidence used to inform this guideline. Development of this guideline was wholly funded by the AGA, with no other additional outside funding.